MX338063B - Molecula de union especifica al rsv. - Google Patents
Molecula de union especifica al rsv.Info
- Publication number
- MX338063B MX338063B MX2012004086A MX2012004086A MX338063B MX 338063 B MX338063 B MX 338063B MX 2012004086 A MX2012004086 A MX 2012004086A MX 2012004086 A MX2012004086 A MX 2012004086A MX 338063 B MX338063 B MX 338063B
- Authority
- MX
- Mexico
- Prior art keywords
- rsv
- specific binding
- binding molecule
- antibody
- producing
- Prior art date
Links
- 230000009870 specific binding Effects 0.000 title 1
- 210000000628 antibody-producing cell Anatomy 0.000 abstract 1
- 150000007523 nucleic acids Chemical group 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
- C07K16/10—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from RNA viruses
- C07K16/1027—Paramyxoviridae, e.g. respiratory syncytial virus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/16—Antivirals for RNA viruses for influenza or rhinoviruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/21—Immunoglobulins specific features characterized by taxonomic origin from primates, e.g. man
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/30—Immunoglobulins specific features characterized by aspects of specificity or valency
- C07K2317/32—Immunoglobulins specific features characterized by aspects of specificity or valency specific for a neo-epitope on a complex, e.g. antibody-antigen or ligand-receptor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/70—Immunoglobulins specific features characterized by effect upon binding to a cell or to an antigen
- C07K2317/76—Antagonist effect on antigen, e.g. neutralization or inhibition of binding
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/90—Immunoglobulins specific features characterized by (pharmaco)kinetic aspects or by stability of the immunoglobulin
- C07K2317/92—Affinity (KD), association rate (Ka), dissociation rate (Kd) or EC50 value
Abstract
La presente invención se refiere a anticuerpos y equivalentes funcionales del mismo que son capaces de enlazar o unirse específicamente al RSV. También se proporcionan las secuencias de ácido nucleico que codifican dicho anticuerpo, así como las células que producen el anticuerpo y métodos para producir dicho anticuerpo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PCT/NL2009/050599 WO2011043643A1 (en) | 2009-10-06 | 2009-10-06 | Rsv-specific binding molecule |
Publications (2)
Publication Number | Publication Date |
---|---|
MX2012004086A MX2012004086A (es) | 2012-09-12 |
MX338063B true MX338063B (es) | 2016-04-01 |
Family
ID=42153917
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MX2012004086A MX338063B (es) | 2009-10-06 | 2009-10-06 | Molecula de union especifica al rsv. |
Country Status (13)
Country | Link |
---|---|
EP (1) | EP2486053B1 (es) |
JP (1) | JP5734988B2 (es) |
KR (1) | KR101789343B1 (es) |
CN (1) | CN102712692B (es) |
AU (1) | AU2009353693B2 (es) |
CA (1) | CA2776249C (es) |
ES (1) | ES2621458T3 (es) |
IL (1) | IL219021A (es) |
MX (1) | MX338063B (es) |
NZ (1) | NZ599148A (es) |
RU (2) | RU2540020C2 (es) |
WO (1) | WO2011043643A1 (es) |
ZA (1) | ZA201202502B (es) |
Families Citing this family (29)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US9005974B2 (en) | 2005-12-09 | 2015-04-14 | Academish Medisch Centrum Bij De Universiteit Van Amsterdam | Means and methods for influencing the stability of cells |
WO2007067046A1 (en) | 2005-12-09 | 2007-06-14 | Academisch Medisch Centrum Bij De Universiteit Van Amsterdam | Means and methods for influencing the stability of antibody producing cells |
EP4001409A1 (en) | 2006-03-31 | 2022-05-25 | Chugai Seiyaku Kabushiki Kaisha | Methods for controlling blood pharmacokinetics of antibodies |
EP1997830A1 (en) | 2007-06-01 | 2008-12-03 | AIMM Therapeutics B.V. | RSV specific binding molecules and means for producing them |
CN101874042B9 (zh) | 2007-09-26 | 2019-01-01 | 中外制药株式会社 | 利用cdr的氨基酸取代来改变抗体等电点的方法 |
NZ602884A (en) | 2008-04-11 | 2014-08-29 | Chugai Pharmaceutical Co Ltd | Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly |
CA2768207C (en) | 2009-07-15 | 2019-12-03 | Aimm Therapeutics B.V. | Means and methods for producing high affinity antibodies |
US8568726B2 (en) | 2009-10-06 | 2013-10-29 | Medimmune Limited | RSV specific binding molecule |
KR102385507B1 (ko) | 2010-11-30 | 2022-04-12 | 추가이 세이야쿠 가부시키가이샤 | 복수 분자의 항원에 반복해서 결합하는 항원 결합 분자 |
NZ611600A (en) * | 2010-12-02 | 2015-02-27 | Aimm Therapeutics Bv | Means and methods for producing high affinity antibodies |
US20140093496A1 (en) | 2011-02-25 | 2014-04-03 | Chugai Seiyaku Kabushiki Kaisha | Fc-gamma-RIIb-SPECIFIC Fc ANTIBODY |
WO2013047748A1 (ja) | 2011-09-30 | 2013-04-04 | 中外製薬株式会社 | 複数の生理活性を有する抗原の消失を促進する抗原結合分子 |
TW201817745A (zh) | 2011-09-30 | 2018-05-16 | 日商中外製藥股份有限公司 | 具有促進抗原清除之FcRn結合域的治療性抗原結合分子 |
WO2013095091A2 (en) | 2011-11-17 | 2013-06-27 | Aimm Therapeutics B.V. | Rsv g protein specific antibodies |
KR20140100532A (ko) | 2011-11-30 | 2014-08-14 | 추가이 세이야쿠 가부시키가이샤 | 면역 복합체를 형성하는 세포내로의 운반체(캐리어)를 포함하는 의약 |
RU2729831C2 (ru) | 2012-08-24 | 2020-08-12 | Чугаи Сейяку Кабусики Кайся | ВАРИАНТЫ FcγRIIB-СПЕЦИФИЧЕСКОЙ Fc-ОБЛАСТИ |
WO2014121021A1 (en) | 2013-02-01 | 2014-08-07 | Medimmune, Llc | Respiratory syncytial virus f protein epitopes |
CA2902877A1 (en) | 2013-03-13 | 2014-10-02 | Jeffrey Boyington | Prefusion rsv f proteins and their use |
US9738689B2 (en) | 2013-03-13 | 2017-08-22 | The United States Of America, As Represented By The Secretary, Department Of Health And Human Services | Prefusion RSV F proteins and their use |
JP6462599B2 (ja) * | 2013-03-15 | 2019-01-30 | シャアメン ユニバーシティ | Rsv融合タンパク質のエピトープ及びそのエピトープを認識する抗体 |
EP3783017A1 (en) | 2013-04-02 | 2021-02-24 | Chugai Seiyaku Kabushiki Kaisha | Fc region variant |
CA2933200A1 (en) | 2014-01-15 | 2015-07-23 | Medimmune, Llc | Rsv-specific antibodies and functional parts thereof |
BR112016017597A2 (pt) | 2014-01-31 | 2017-08-08 | Aimm Therapeutics Bv | Métodos para produzir uma célula b, para selecionar pelo menos uma célula b, para produzir anticorpos específicos para um antígeno de interesse e para identificar pelo menos uma mutação na sequência de aminoácido da cadeia pesada e/ou cadeia leve de um anticorpo |
JO3555B1 (ar) | 2015-10-29 | 2020-07-05 | Merck Sharp & Dohme | جسم مضاد يبطل فعالية فيروس الالتهاب الرئوي البشري |
CN106496324B (zh) | 2015-11-30 | 2020-01-14 | 天津昊免生物技术有限公司 | 一种抗呼吸道合胞病毒的全人源抗体 |
KR20230035429A (ko) | 2015-12-23 | 2023-03-13 | 화이자 인코포레이티드 | Rsv f 단백질 돌연변이체 |
TWI761453B (zh) | 2017-03-01 | 2022-04-21 | 英商梅迪繆思有限公司 | 抗rsv單株抗體配製物 |
RU2713340C1 (ru) * | 2018-12-28 | 2020-02-04 | Федеральное государственное бюджетное учреждение "Научно-исследовательский институт гриппа имени А.А. Смородинцева" Министерства здравоохранения Российской Федерации | Моноклональные антитела, специфичные к различным штаммам респираторно-синцитиального вируса |
WO2024069420A2 (en) | 2022-09-29 | 2024-04-04 | Pfizer Inc. | Immunogenic compositions comprising an rsv f protein trimer |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6020182A (en) * | 1996-07-12 | 2000-02-01 | Connaught Laboratories Limited | Subunit respiratory syncytial virus vaccine preparation |
AU2003295411A1 (en) * | 2002-11-07 | 2004-06-03 | Celltech R & D | Human monoclonal antibodies to heparanase |
WO2005079479A2 (en) * | 2004-02-17 | 2005-09-01 | Absalus, Inc. | Super-humanized antibodies against respiratory syncytial virus |
EP1997830A1 (en) * | 2007-06-01 | 2008-12-03 | AIMM Therapeutics B.V. | RSV specific binding molecules and means for producing them |
AU2008295248A1 (en) * | 2007-09-07 | 2009-03-12 | Symphogen A/S | Methods for recombinant manufacturing of anti-RSV antibodies |
US9873957B2 (en) * | 2008-03-13 | 2018-01-23 | Dyax Corp. | Libraries of genetic packages comprising novel HC CDR3 designs |
-
2009
- 2009-10-06 JP JP2012533099A patent/JP5734988B2/ja not_active Expired - Fee Related
- 2009-10-06 WO PCT/NL2009/050599 patent/WO2011043643A1/en active Application Filing
- 2009-10-06 KR KR1020127011652A patent/KR101789343B1/ko active IP Right Grant
- 2009-10-06 RU RU2012118636/10A patent/RU2540020C2/ru active
- 2009-10-06 ES ES09788359.9T patent/ES2621458T3/es active Active
- 2009-10-06 NZ NZ599148A patent/NZ599148A/en not_active IP Right Cessation
- 2009-10-06 MX MX2012004086A patent/MX338063B/es active IP Right Grant
- 2009-10-06 EP EP09788359.9A patent/EP2486053B1/en not_active Not-in-force
- 2009-10-06 AU AU2009353693A patent/AU2009353693B2/en not_active Ceased
- 2009-10-06 CA CA2776249A patent/CA2776249C/en active Active
- 2009-10-06 CN CN200980162731.3A patent/CN102712692B/zh not_active Expired - Fee Related
-
2012
- 2012-04-03 IL IL219021A patent/IL219021A/en active IP Right Grant
- 2012-04-05 ZA ZA2012/02502A patent/ZA201202502B/en unknown
-
2014
- 2014-12-19 RU RU2014151788A patent/RU2014151788A/ru not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
RU2014151788A (ru) | 2016-07-10 |
NZ599148A (en) | 2014-08-29 |
RU2540020C2 (ru) | 2015-01-27 |
KR101789343B1 (ko) | 2017-10-23 |
RU2014151788A3 (es) | 2018-07-09 |
CA2776249A1 (en) | 2011-04-14 |
IL219021A0 (en) | 2012-06-28 |
BR112012008173A2 (pt) | 2017-10-10 |
CN102712692B (zh) | 2014-12-31 |
JP5734988B2 (ja) | 2015-06-17 |
IL219021A (en) | 2016-11-30 |
AU2009353693A1 (en) | 2012-04-19 |
MX2012004086A (es) | 2012-09-12 |
ZA201202502B (en) | 2014-06-25 |
KR20120084755A (ko) | 2012-07-30 |
WO2011043643A1 (en) | 2011-04-14 |
RU2012118636A (ru) | 2013-11-20 |
EP2486053A1 (en) | 2012-08-15 |
AU2009353693B2 (en) | 2016-07-21 |
JP2013506431A (ja) | 2013-02-28 |
CN102712692A (zh) | 2012-10-03 |
CA2776249C (en) | 2021-01-19 |
EP2486053B1 (en) | 2017-01-18 |
ES2621458T3 (es) | 2017-07-04 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MX338063B (es) | Molecula de union especifica al rsv. | |
MX2009012843A (es) | Moleculas de union especificas de virus sincitial respiratorio y medios para producirlas. | |
HK1245802A1 (zh) | 多特異性抗體、抗體類似物、組合物和方法 | |
WO2010145792A8 (en) | Bispecific antigen binding proteins | |
SG179196A1 (en) | Coiled coil and/or tether containing protein complexes and uses thereof | |
WO2011079902A3 (en) | Biological inhibitors of ror1 capable of inducing cell death | |
MX2010008099A (es) | Anticuerpos y angiopoyetina-2 estabilizados y sus usos. | |
EA201171148A1 (ru) | Антитело-антагонист, специфичное для гетеродимера альфа-4-бета-7 | |
MX2012007340A (es) | Anticuerpos anti/her3 y usos de los mismos. | |
WO2014089335A3 (en) | Bcma antigen binding proteins | |
IL217827A0 (en) | Muc1 antibodies, nucleic acids encoding the same and methods for producing the same | |
WO2009112245A9 (en) | Antibody against the csf-1 r | |
TW201129381A (en) | Antibodies against human CSF-1R and uses thereof | |
WO2009128963A3 (en) | Cross-neutralizing human monoclonal antibodies to sars-cov and methods of use thereof | |
WO2010127304A3 (en) | Sequencing methods | |
WO2009052400A8 (en) | Antibodies that bind to mammalian ngal and uses thereof | |
WO2012109373A3 (en) | Treatment of osteoarthritis and pain | |
PH12013502205A1 (en) | Antibodies to il-6 and their uses | |
NZ592432A (en) | Antibodies that specifically block the biological activity of a tumor antigen Kidney associated antigen 1 (KAAG1) | |
WO2008048519A3 (en) | Antibodies that bind cxcr7 epitopes | |
SG178886A1 (en) | Humanized anti-cdcp1 antibodies | |
EP1992698A4 (en) | METHOD FOR SYNTHESIS OF SUPPRESSOR TRNA, DNA CONSTRUCT AND PREPARATION OF PROTEIN WITH INTEGRATED NON-NATURAL AMINO ACID USING THE DNA CONSTRUCTURE | |
WO2009130459A3 (en) | Epitopes of il-17a and il-17f and antibodies specific thereto | |
WO2010121093A3 (en) | Humanized antibody compositions and methods for binding lysophosphatidic acid | |
WO2010136483A3 (en) | Antigen-binding proteins |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |